anjalee.khemlani@yahoofinance.com | DM for Signal
#biosky #medsky #publichealth #idsky #pharmasky #news #skyrx #econsky
www.statnews.com/2025/05/02/n...
www.statnews.com/2025/05/02/n...
Let me know how you found me!
I post healthcare things (mostly business and policy) and also share random interesting posts.
Anything that makes my brain feel awake and challenged..... in a critical/non-ragey kind of way 🧠
Let me know how you found me!
I post healthcare things (mostly business and policy) and also share random interesting posts.
Anything that makes my brain feel awake and challenged..... in a critical/non-ragey kind of way 🧠
finance.yahoo.com/news/declare...
finance.yahoo.com/news/declare...
Once again....
History here: www.tiktok.com/t/ZTjku6rRj/
Once again....
History here: www.tiktok.com/t/ZTjku6rRj/
www.thelancet.com/journals/lan...
www.thelancet.com/journals/lan...
finance.yahoo.com/news/why-vac...
finance.yahoo.com/news/why-vac...
www.statnews.com/2025/04/06/r...
www.statnews.com/2025/04/06/r...
finance.yahoo.com/news/fda-del...
finance.yahoo.com/news/fda-del...
Now, as a ~6yr @yahoofinance.com vet, I know my healthcare stocks in an instant.
DGX Quest Diagnostics
GSK GlaxoSmithKline
RAD..good ol Rite Aid, no longer publicly traded
(Movie: The Big Short)
Now, as a ~6yr @yahoofinance.com vet, I know my healthcare stocks in an instant.
DGX Quest Diagnostics
GSK GlaxoSmithKline
RAD..good ol Rite Aid, no longer publicly traded
(Movie: The Big Short)
-On reducing asthma from mold
-On prenatal risks & screening
-On statins influence on dementia
-On the safety/risk of gender-affirming care
-On how Covid vax outcomes & disparities
-On improving HIV care
-Training programs for the next generation of scientists
-On reducing asthma from mold
-On prenatal risks & screening
-On statins influence on dementia
-On the safety/risk of gender-affirming care
-On how Covid vax outcomes & disparities
-On improving HIV care
-Training programs for the next generation of scientists
www.linkedin.com/posts/anjkhe...
www.linkedin.com/posts/anjkhe...
finance.yahoo.com/news/multipl...
finance.yahoo.com/news/multipl...
finance.yahoo.com/news/multipl...
finance.yahoo.com/news/trickle...
finance.yahoo.com/news/trickle...
Here is Novo Nordisk's breakdown of it's patient access breakdown, and why it isn't fazed by IRA Medicare drug pricing negotiation for GLP-1 semaglutide products.
50% commercial
30% Medicare
10% Medicaid
10% other
finance.yahoo.com/news/novo-no...
Here is Novo Nordisk's breakdown of it's patient access breakdown, and why it isn't fazed by IRA Medicare drug pricing negotiation for GLP-1 semaglutide products.
50% commercial
30% Medicare
10% Medicaid
10% other
finance.yahoo.com/news/novo-no...